Home/Filings/4/0001193125-25-326891
4//SEC Filing

LIGAND PHARMACEUTICALS INC 4

Accession 0001193125-25-326891

$LGNDCIK 0001919246operating

Filed

Dec 18, 7:00 PM ET

Accepted

Dec 19, 4:15 PM ET

Size

9.8 KB

Accession

0001193125-25-326891

Insider Transaction Report

Form 4
Period: 2025-12-17
Transactions
  • Disposition to Issuer

    Senior Secured Convertible Note

    2025-12-170 total
    Exercise: $34.44From: 2025-11-06Exp: 2027-11-06Common Stock (261,309 underlying)
  • Award

    Senior Secured Convertible Note

    2025-12-17
    Exercise: $29.73From: 2025-11-06Exp: 2027-11-06Common Stock (302,724 underlying)
Footnotes (2)
  • [F1]On November 6, 2025, Pelthos Therapeutics Inc. (the "Issuer") entered into a Securities Purchase Agreement with the reporting person and certain other investors, pursuant to which the Issuer issued a senior secured convertible note (the "Convertible Note") in the aggregate principal amount of $9 million to the reporting person on November 6, 2025. The Convertible Note may be converted into Common Stock at a conversion price of $34.442 per share. The Convertible Note includes a beneficial ownership limitation of 49.9% with respect to the reporting person.
  • [F2]On December 17, 2025, at the annual meeting of the Issuer's shareholders, the Issuer's shareholders approved the waiver of the limit on the number of shares of Common Stock that may be issued to the holders of the Convertible Notes pursuant to the rules of the NYSE American LLC, which requires shareholder approval before issuing common stock (or securities convertible into or exercisable for common stock) in a private placement that constitutes 20% or more of the Issuer's pre-transaction outstanding common stock. As a result, the conversion price of the Convertible Note was reduced from $34.442 per share to $29.73 per share. The reduction in the conversion price is reported above as the cancellation of a Convertible Note and the acquisition of a new Convertible Note.

Documents

1 file

Issuer

Pelthos Therapeutics Inc.

CIK 0001919246

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000886163

Filing Metadata

Form type
4
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 4:15 PM ET
Size
9.8 KB